Catestatin in innate immunity and Cateslytin-derived peptides against superbugs

Abstract Chromogranin A (CgA) is the precursor of several antimicrobial peptides, such as Catestatin (Cts, bovine CgA344-364), initially described as a potent inhibitor of catecholamines. This peptide displays direct antimicrobial activities and contributes to immune system regulation. The aim of th...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Francesco Scavello, Angela Mutschler, Sophie Hellé, Francis Schneider, Sylvette Chasserot-Golaz, Jean-Marc Strub, Sarah Cianferani, Youssef Haikel, Marie-Hélène Metz-Boutigue
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/902cf7b567b743c0ab768f0daa34fe84
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:902cf7b567b743c0ab768f0daa34fe84
record_format dspace
spelling oai:doaj.org-article:902cf7b567b743c0ab768f0daa34fe842021-12-02T18:49:16ZCatestatin in innate immunity and Cateslytin-derived peptides against superbugs10.1038/s41598-021-94749-62045-2322https://doaj.org/article/902cf7b567b743c0ab768f0daa34fe842021-08-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-94749-6https://doaj.org/toc/2045-2322Abstract Chromogranin A (CgA) is the precursor of several antimicrobial peptides, such as Catestatin (Cts, bovine CgA344-364), initially described as a potent inhibitor of catecholamines. This peptide displays direct antimicrobial activities and contributes to immune system regulation. The aim of the present study is to investigate a designed peptide based on Cts to fight infections against superbugs and more particularly Staphylococcus aureus. In addition to Cateslytin (Ctl, bovine CgA344-358), the active domain of Catestatin, several peptides including dimers, D-isomer and the new designed peptide DOPA-K-DOPA-K-DOPA-TLRGGE-RSMRLSFRARGYGFR (Dopa5T-Ctl) were prepared and tested. Cateslytin is resistant to bacterial degradation and does not induce bacterial resistance. The interaction of Catestatin with immune dermal cells (dendritic cells DC1a, dermal macrophages CD14 and macrophages) was analyzed by using confocal microscopy and cytokine release assay. The dimers and D-isomer of Ctl were tested against a large variety of bacteria showing the potent antibacterial activity of the D-isomer. The peptide Dopa5T-Ctl is able to induce the self-killing of S. aureus after release of Ctl by the endoprotease Glu-C produced by this pathogen. It permits localized on-demand delivery of the antimicrobial drug directly at the infectious site.Francesco ScavelloAngela MutschlerSophie HelléFrancis SchneiderSylvette Chasserot-GolazJean-Marc StrubSarah CianferaniYoussef HaikelMarie-Hélène Metz-BoutigueNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-14 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Francesco Scavello
Angela Mutschler
Sophie Hellé
Francis Schneider
Sylvette Chasserot-Golaz
Jean-Marc Strub
Sarah Cianferani
Youssef Haikel
Marie-Hélène Metz-Boutigue
Catestatin in innate immunity and Cateslytin-derived peptides against superbugs
description Abstract Chromogranin A (CgA) is the precursor of several antimicrobial peptides, such as Catestatin (Cts, bovine CgA344-364), initially described as a potent inhibitor of catecholamines. This peptide displays direct antimicrobial activities and contributes to immune system regulation. The aim of the present study is to investigate a designed peptide based on Cts to fight infections against superbugs and more particularly Staphylococcus aureus. In addition to Cateslytin (Ctl, bovine CgA344-358), the active domain of Catestatin, several peptides including dimers, D-isomer and the new designed peptide DOPA-K-DOPA-K-DOPA-TLRGGE-RSMRLSFRARGYGFR (Dopa5T-Ctl) were prepared and tested. Cateslytin is resistant to bacterial degradation and does not induce bacterial resistance. The interaction of Catestatin with immune dermal cells (dendritic cells DC1a, dermal macrophages CD14 and macrophages) was analyzed by using confocal microscopy and cytokine release assay. The dimers and D-isomer of Ctl were tested against a large variety of bacteria showing the potent antibacterial activity of the D-isomer. The peptide Dopa5T-Ctl is able to induce the self-killing of S. aureus after release of Ctl by the endoprotease Glu-C produced by this pathogen. It permits localized on-demand delivery of the antimicrobial drug directly at the infectious site.
format article
author Francesco Scavello
Angela Mutschler
Sophie Hellé
Francis Schneider
Sylvette Chasserot-Golaz
Jean-Marc Strub
Sarah Cianferani
Youssef Haikel
Marie-Hélène Metz-Boutigue
author_facet Francesco Scavello
Angela Mutschler
Sophie Hellé
Francis Schneider
Sylvette Chasserot-Golaz
Jean-Marc Strub
Sarah Cianferani
Youssef Haikel
Marie-Hélène Metz-Boutigue
author_sort Francesco Scavello
title Catestatin in innate immunity and Cateslytin-derived peptides against superbugs
title_short Catestatin in innate immunity and Cateslytin-derived peptides against superbugs
title_full Catestatin in innate immunity and Cateslytin-derived peptides against superbugs
title_fullStr Catestatin in innate immunity and Cateslytin-derived peptides against superbugs
title_full_unstemmed Catestatin in innate immunity and Cateslytin-derived peptides against superbugs
title_sort catestatin in innate immunity and cateslytin-derived peptides against superbugs
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/902cf7b567b743c0ab768f0daa34fe84
work_keys_str_mv AT francescoscavello catestatinininnateimmunityandcateslytinderivedpeptidesagainstsuperbugs
AT angelamutschler catestatinininnateimmunityandcateslytinderivedpeptidesagainstsuperbugs
AT sophiehelle catestatinininnateimmunityandcateslytinderivedpeptidesagainstsuperbugs
AT francisschneider catestatinininnateimmunityandcateslytinderivedpeptidesagainstsuperbugs
AT sylvettechasserotgolaz catestatinininnateimmunityandcateslytinderivedpeptidesagainstsuperbugs
AT jeanmarcstrub catestatinininnateimmunityandcateslytinderivedpeptidesagainstsuperbugs
AT sarahcianferani catestatinininnateimmunityandcateslytinderivedpeptidesagainstsuperbugs
AT youssefhaikel catestatinininnateimmunityandcateslytinderivedpeptidesagainstsuperbugs
AT mariehelenemetzboutigue catestatinininnateimmunityandcateslytinderivedpeptidesagainstsuperbugs
_version_ 1718377574080446464